Introduction
Over the past 15 years, several groups of researchers have sought to use clinical trials to reintroduce psychedelics to mainstream society, reporting impressive efficacy from trials at university sites such as Johns Hopkins, New York University and Imperial College London, in the treatment of clinical targets such as unipolar depression and anxiety, addiction and post-traumatic stress disorder (PTSD) …
A Workshop Report by the Neuroscience and Society Network
The Neuroscience and Society Network organised a workshop on 11-12 July 2018 at the Institute of Psychology, Psychiatry and Neuroscience (IoPPN) at King’s College London (KCL) titled “The Mercurial Life Of Drugs: Psychedelics As Models, Risk Factors, And Treatments For Mental Disorders”. In the workshop, we explored what makes psychedelic …
“They used my ass and took advantage of me.” This was the story of Eddie Flowers, a former drug addict used in LSD experiments during the 1950s. Leaning forward, forearms on desk, Flowers spoke into the microphone on Capital Hill during the 1975 U.S. Senate hearings into secret government-sponsored research (known as the Church Committee hearings). Flowers died in 2009 …
Neuropsychedelia: The Revival of Hallucinogen Research Since the Decade of the Brain
University of California Press, 2012, 336 pages.
Humphry Osmond wrote to Aldous Huxley in 1956 proposing the term “psychedelic,” coined from two Greek words to mean “mind manifesting.” The scholars, one a psychiatrist and the other a celebrated novelist and philosopher, were exuberant about the …